Peter Finelli
Psychiatry · Doylestown, PANPI 1033310560
Payments from drug & device makers
Across 162 payments — averaging $22.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$720
- Supernus Pharmaceuticals, Inc.$550
- Takeda Pharmaceuticals U.S.A., Inc.$384
- Lundbeck LLC$341
- Sunovion Pharmaceuticals Inc.$329
- Otsuka America Pharmaceutical, Inc.$173
- plus $1K from 20 others
Across 2 payments — averaging $2187.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orexo US, Inc.$4K
What the payments were for
- Speaking & faculty fees$50014%
- Food & beverage$3,13885%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 31 | $720 |
| Supernus Pharmaceuticals, Inc. | 3 | $550 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $384 |
| Lundbeck LLC | 19 | $341 |
| Sunovion Pharmaceuticals Inc. | 22 | $329 |
| Otsuka America Pharmaceutical, Inc. | 9 | $173 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 7 | $167 |
| Orexo US, Inc. | 10 | $146 |
| Corium, LLC | 6 | $128 |
| Johnson & Johnson | 4 | $121 |
| Axsome Therapeutics, Inc. | 5 | $118 |
| Shire North American Group Inc | 5 | $83 |
| Idorsia Pharmaceuticals US Inc | 4 | $77 |
| Almatica Pharma LLC | 4 | $67 |
| Eisai Inc. | 3 | $59 |
| Braeburn Inc. | 2 | $41 |
| Alkermes, Inc. | 1 | $23 |
| Neos Therapeutics, LP | 1 | $23 |
| Bausch Health US, LLC | 1 | $23 |
| Indivior Inc. | 1 | $19 |
| Adlon Therapeutics L.p. | 1 | $18 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Merck | 1 | $15 |
| Vanda Pharmaceuticals Inc. | 1 | $14 |
| Sumitomo Pharma America, Inc. | 1 | $11 |
How this compares
$3,685 in reported general payments places this provider in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| AuvelityDextromethorphan Hbr/Bupropion | 13 | $14,128 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 136 | $9,102 |
| ZubsolvBuprenorphine Hcl/Naloxone Hcl | 15 | $7,340 |
| Dextroamphetamine Sulfate | 15 | $6,436 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 148 | $3,788 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 18 | $2,704 |
| Paliperidone ErPaliperidone | 26 | $2,454 |
| Buprenorphine Hcl | 38 | $2,126 |
| Aripiprazole | 20 | $1,525 |
| Alprazolam ErAlprazolam | 26 | $1,016 |
| Bupropion XlBupropion Hcl | 56 | $760 |
| Gabapentin | 53 | $627 |
| Lorazepam | 63 | $563 |
| Duloxetine Hcl | 70 | $538 |
| Lithium Carbonate ErLithium Carbonate | 27 | $527 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Axsome Therapeutics, Inc.Auvelity | $118 | $14,12813 claims |
| Orexo US, Inc.Zubsolv | $146 | $7,34015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,838 psychiatry providers in Pennsylvania.
Other psychiatry in Doylestown
- Cherian VergheseNorristown$16.3M
- Steven ArnoldPhiladelphia$4.1M
- Paul GrossAllentown$4.1M
- Shivkumar HattiMedia$4M
- Rebecca RomaPittsburgh$3.3M
- Matthew BergerMoosic$2.4M
- Michael ThasePhiladelphia$2.2M
- Robert NelsonWyomissing$2.2M
- Mark MattaNew Castle$847K
- Mayer AyyashPittsburgh$714K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.